Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
IGM Biosciences, Inc.
Dartmouth-Hitchcock Medical Center
Sarcoma Alliance for Research through Collaboration